Immunex Preparing Enbrel Infection Risk Study And BLA For RA Progression

Immunex has agreed to perform large, prospectively defined studies to assess the risk of serious infection related to use of its rheumatoid arthritis therapy Enbrel (etanercept) following reports of sepsis and death with the product.